Future directions in the treatment of patients with Hodgkin Lymphoma
The department of Radiation Oncology is very pleased to invite you to our upcoming research meeting ‘Noordelijke Refereeravond Radiotherapie’.
Radiotherapy and systemic treatment are both cornerstones in the treatment of Hodgkin Lymphoma, resulting in high cure rates. Despite the developments over the last decades, late treatment-related complications, especially cardiac toxicity and secondary malignancies, are remaining side effects. Insight in the factors contributing to the development of these side effects is crucial to develop primary and secondary preventive strategies.
Primary prevention in radiotherapy mainly focuses on reducing the radiation dose to or- gans at risk by new radiation technologies. Despite the introduction of new photon-based technologies, radiation dose to normal tissues still is substantial.
At present, the national indication protocol for proton therapy is under development. During this research meeting, a number of experts in the field will discuss the limitations of current treatment of Hodgkin lymphoma and the potential advantages and challenges related to the introduction of proton therapy.
Radiation oncologists, hematologists, residents, medical physicists and RTT’s.
Program and speakers: Program (download)
Time: 17:30 - 20:30, Wednesday February 27th
Location: UMCG Lokaal 16 Onderwijscentrum
Please be aware that registration in advance is mandatory. Registration will be on the ‘first come, first serve’ basis. We kindly request you to register at: email@example.com